Chimeric Therapeutics Limited - Ordinary Fully Paid Deferred

Camplify Holdings Ltd. operates in the RV rental market. The firm has built a platform that delivers transparent experiences for consumers and RV hirers to connect with RV owners and small and medium-sized enterprises (SMEs) with a fleet of RVs. Its businesses include Camplify and PaulCamper. Its segments include Hire, Membership and Other. The firm provides a range of caravans, motorhomes, camper trailers and campervans for hire via the respective platforms. The firm has operations in Australia, New Zealand, Spain, United Kingdom, Germany, Austria and Netherlands. Its subsidiaries include Camplify Co (Australia) Pty Ltd, Camplify Co (NZ) Limited, Camplify Co (UK) Limited, Plataforma Camplify Espana, S.L and PaulCamper GmbH.

Camplify Holdings Limited

Chimeric Therapeutics Ltd. develops Chlorotixin CAR-T technology based cell therapies for the curation of solid tumors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-01-18. The firm is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase I clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The firm is also focused on the development of four NK and CAR NK assets with plans for Phase I clinical trials in solid tumors and blood cancers.

Chimeric Therapeutics Ltd

Chimeric Therapeutics Limited

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. The company is headquartered in Sydney, New South Wales.  The firm is engaged in developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its product pipeline includes multiple immunotherapy B-cell vaccine candidates and oncolytic virotherapy (CF33) aimed at treating a variety of cancers in combination with standard of care drugs and emerging immunotherapies, such as CAR T’s for solid tumors. Its HER-Vaxx is a B-cell immuno-therapy designed to treat tumors that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. PD1-Vaxx is a B-cell immuno-therapy, which aims to induce the body to produce polyclonal antibodies that block PD-1 signaling, and thus produce an anticancer. Its clinical trial candidates include VAXINIA, CHECKvacc, B-Vaxx and others. Its platform technologies seek to harness the body’s immune system against tumors.

Imugene Limited (IMU) is an Australian immuno-oncology focused Biopharmaceutical Company developing HER2 + ve gastric and breast cancer vaccines. The Group's lead product is HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu.



Imugene Limited

VAE.AX was created on 2015-12-09 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard FTSE Asia ex Japan Shares Index ETF seeks to track the return of the FTSE Asia Pacific ex Japan, Australia and New Zealand Index (with net dividends reinvested) in Australian dollars, before taking into account fees, expenses and tax.

Vanguard FTSE Asia ex Japan Shares Index ETF seeks to track the return of the FTSE Asia Pacific ex Japan, Australia and New Zealand Index (with net dividends reinvested) in Australian dollars, before taking into account fees, expenses and tax.

Vanguard Ftse Asia Ex Japan Shares Index Etf

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the  performance of the Solactive Battery ValueChain Index (the Index).

ETFS Battery Tech & Lithium ETF aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery Value-Chain Index by holding all of the shares that make up the index closely in proportion to their index weights.

ACDC is Australia’s first ETF to provide exposure to the energy storage and production megatrend. ACDC provides investors with access to companies involved in battery technology and lithium mining. The index covers all electro-chemical storage, not just lithium, in order to capture the growth of the whole industry. ACDC is a global portfolio covering multiple regions and sectors and adopts an equal weight strategy.

FAIR.AX was created on 2017-11-27 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes Australian companies that have passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

BetaShares Australian Sustainability Leaders ETF (FAIR) provides exposure to Australian companies that have passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations. The Fund’s methodology also preferences companies classified as “Sustainability Leaders” based on their involvement in sustainable business activities.

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

The iShares S&P 500 ETF seeks to track the investment results of an index composed of large-capitalisation U.S. equities.

iShares S&P 500 Etf

A2B Australia Ltd. engages in the provision of taxi charge account and related services to the taxi industry. The company is headquartered in Alexandria, New South Wales.  The firm provides taxi network services to taxi operators and drivers nationally in Australia. Its network services include taxi booking services, full taxi fit outs and repairs, vehicle financing and insurance, as well as driver training and education. The Company’s mobility Services are provided under brands, including 13cabs, Silver Service and Maxi Taxi. The company provides integrated booking, payment and safety technologies to taxi and private hire businesses under brands, including Cabcharge and Mobile Technologies International. Its Cabcharge provides payment terminals enabling drivers to process non-cash trip payments. Its Mobile Technologies International provides a vehicle monitoring platform. The firm also provides payment consulting, software, processing and terminals under brands, including EFT Solutions, Spotto, Giraffe and FlamingoPay.

A2B Australia Limited

ARN Media Ltd is a AU-based company operating in Media industry. The company is headquartered in Macquarie, New South Wales.  ARN Media Limited, formerly HT&E Limited, is an Australia-based broadcast and on-demand audio company. The firm owns approximately 58 radio stations across 33 markets plus 46 digital audio broadcasting (DAB+) stations nationwide. The firm's portfolio of brands includes KIIS Network, Pure Gold Network, CADA, Regional, iHeartRadio, and iHeartPodcast Network. KIIS Network includes KIIS stations, KIIS 1065, KIIS 101.1, and KIIS 97.3. Pure Gold Network delivers a combination of music, intelligent content and timeless entertainment to the Gen X audience. Its digital entertainment platform iHeartRadio app is an all-in-one radio, music streaming, podcast, and live events platform available to Australians in every state. Audiences can also access their favorite stations in Australia from ARN, Special Broadcasting Service (SBS) and stations from New Zealand and the United States. Its iHeartPodcast Network Australia is the preeminent podcast destination for creators, brands and audiences.

Arn Media Limited

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

BetaShares Australia 200 ETF

Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). These are mostly large and established Australian companies. It is a popular choice among passive individual investors who don't have the time or the expertise to actively invest in stocks.

Vanguard Australian Shares Index Etf

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

Vanguard MSCI Index International Shares Etf

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

	CHM	A200
Popularity	Low	Medium
Pearlers invested	7	3,368
Median incremental investment	$3,480.50	$1,084.57
Median investment frequency	N/A	N/A
Median total investment	$599.51	$2,536.59
Average age group	N/A	N/A

	CHM	A200
Strategy	N/A	A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
Top 3 holdings	Chimeric Therapeutics Limited (100 %)	BHP GROUP LTD (10.26 %) COMMONWEALTH BANK OF AUSTRALIA (7.91 %) CSL LTD (7.07 %)
Top 3 industries	Health Care (100 %)	Financials (27.20 %) Materials (22.98 %) Health Care (9.84 %)
Top 3 countries	Australia (100 %)	Australia (96.56 %) New Zealand (1.24 %) Ireland (0.80 %)
Management fee	N/A	0.04 %

	CHM	A200
Issuer	N/A	BetaShares
Tracking index	N/A	Solactive Australia 200 Index - AUD
Asset class	Stock	ETF
Management fee	N/A	0.04 %
Price	$0.037	$120.79
Size	$16.610 million	$2.975 billion
10Y return	N/A	N/A
Annual dividend/ distribution yield (5Y)	- %	- %
Market	ASX	ASX
First listed date	17/01/2021	08/05/2018
Purchase fee	$6.50	$6.50

	CHM	A200
Popularity	Low	Medium
Pearlers invested	7	3,368
Median incremental investment	$3,480.50	$1,084.57
Median investment frequency	N/A	N/A
Median total investment	$599.51	$2,536.59
Average age group	N/A	N/A

	CHM	A200
Pros		Exposure to more markets and sectors
Cons	Exposure to 1 market and 1 sector only

Compare AU

Compare CHM vs. A200

Overview

Performance

Industry & Region

Top Holdings

Overview

Community Stats

Key Summary

Key Summary

Community Stats

Pros and Cons